Lens Lab

The Myopia Issue

Your kid's worsening prescription is a movement now — not just "bad eyes."

By James Stone

Issue #1 · Published Oct 19, 2026

Here's something the eyewear world doesn't say loudly enough: childhood myopia keeps climbing. More children are becoming nearsighted, earlier, and their prescriptions are marching stronger every year. If your child's glasses keep getting thicker, you're not imagining it. You're living the trend.

So what are myopia control lenses? In plain English: they're spectacle lenses designed to do more than correct vision. Regular glasses move the focal point so your kid sees clearly today. Myopia control lenses aim to also slow down how quickly the nearsightedness gets worse over time. They use special optical designs — tiny lenslets, defocus zones, dynamic signal patterns — that researchers believe influence how the eye grows. Because in childhood myopia, the eyeball literally grows too long, and longer eyes mean stronger prescriptions.

This is the hottest lens story in eyewear right now, and almost no consumer media is explaining it to parents. Three major players have serious clinical data behind their lenses: Essilor's Stellest, Hoya's MiYOSMART iQ, and ZEISS's MyoActive. The next three pages break down each one — what it is, what the trials showed, where it's available.

A note, and it matters: we explain lenses. We don't diagnose eyes. Every child's situation is different, and only your eye doctor can say what's appropriate for your kid.

Talk to your eye doctor: ask whether myopia management is something to discuss at your child's next exam — and what options exist where you live.

Sources: AAO EyeNet — FDA authorization of Stellest; HOYA — MiYOSMART iQ launch release; ZEISS — MyoActive launch release.